{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:19:01Z","timestamp":1769501941554,"version":"3.49.0"},"reference-count":25,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,11]]},"DOI":"10.31744\/einstein_journal\/2019rw4628","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:51:06Z","timestamp":1563220266000},"source":"Crossref","is-referenced-by-count":7,"title":["Risk profile for antiangiogenic agent-related osteonecrosis of the jaws"],"prefix":"10.31744","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-3894","authenticated-orcid":false,"given":"Raquel D\u2019Aquino Garcia","family":"Caminha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-3048","authenticated-orcid":false,"given":"Gabriela Moura","family":"Chicrala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-7354","authenticated-orcid":false,"suffix":"J\u00fanior","given":"Luiz Alberto Valente","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-3759","authenticated-orcid":false,"given":"Paulo S\u00e9rgio da Silva","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"24","key":"key20190715155100_B1","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J Clin Oncol."},{"issue":"2","key":"key20190715155100_B2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.oraloncology.2011.07.030","article-title":"A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit","volume":"48","author":"Di\u015fel","year":"2012","journal-title":"Oral Oncol."},{"issue":"3","key":"key20190715155100_B3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/039463201202500328","article-title":"Osteonecrosis of the jaws and bevacizumab therapy: a case report","volume":"25","author":"Brunamonti Binello","year":"2012","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"4","key":"key20190715155100_B4","article-title":"Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases","volume":"4","author":"Erovigni","year":"2016","journal-title":"Dent J (Basel)"},{"issue":"Suppl 2","key":"key20190715155100_B5","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.5301\/tj.5000405","article-title":"Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district","volume":"102","author":"Ponzetti","year":"2016","journal-title":"Tumori."},{"issue":"2","key":"key20190715155100_B6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omsc.2017.03.001","article-title":"Osteonecrosis of jaw after antiangiogenic agent administration in a renal cell carcinoma patient","volume":"3","author":"Jung","year":"2017","journal-title":"Oral and Maxillofacial Surgery Cases."},{"issue":"10","key":"key20190715155100_B7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"issue":"4","key":"key20190715155100_B8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10006-012-0379-9","article-title":"Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab","volume":"17","author":"Pakosch","year":"2013","journal-title":"Oral Maxillofac Surg."},{"issue":"12","key":"key20190715155100_B9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/annonc\/mdn653","article-title":"Bevacizumab-associated osteonecrosis of the jaw","volume":"19","author":"Greuter","year":"2008","journal-title":"Ann Oncol."},{"issue":"4","key":"key20190715155100_B10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039463200902200429","article-title":"Bevacizumab-related osteneocrosis of the jaw","volume":"22","author":"Serra","year":"2009","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"1","key":"key20190715155100_B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","article-title":"Osteonecrosis of the jaw related to sunitinib","volume":"15","author":"Koch","year":"2011","journal-title":"Oral Maxillofac Surg."},{"key":"key20190715155100_B12","doi-asserted-by":"crossref","first-page":"pii","DOI":"10.1136\/bcr-2012-007284","article-title":"Bevacizumab-related osteonecrosis of the mandible is a self-limiting disease process","volume":"2012","author":"Bettini","year":"2012","journal-title":"BMJ Case Rep."},{"issue":"2","key":"key20190715155100_B13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tripleo.2011.08.024","article-title":"Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications","volume":"113","author":"Nicolatou-Galitis","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"3","key":"key20190715155100_B14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","article-title":"Osteonecrosis after administration of intravitreous bevacizumab","volume":"70","author":"Hopp","year":"2012","journal-title":"J Oral Maxillofac Surg."},{"issue":"3","key":"key20190715155100_B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"1","key":"key20190715155100_B16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2012.03.022","article-title":"Unusual bevacizumab-related complication of an oral infection","volume":"71","author":"Magremanne","year":"2013","journal-title":"J Oral Maxillofac Surg."},{"issue":"6","key":"key20190715155100_B17","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","article-title":"Osteonecrosis of the mandible associated with bevacizumab therapy","volume":"115","author":"Santos-Silva","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"4","key":"key20190715155100_B18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/adj.12254","article-title":"Osteonecrosis of the jaw in a patient receiving cabozantinib","volume":"60","author":"Marino","year":"2015","journal-title":"Aust Dent J."},{"issue":"Suppl 2","key":"key20190715155100_B19","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.5301\/tj.5000504","article-title":"Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma","volume":"102","author":"Garuti","year":"2016","journal-title":"Tumori."},{"issue":"5 Suppl","key":"key20190715155100_B20","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg."},{"issue":"9","key":"key20190715155100_B21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"issue":"5","key":"key20190715155100_B22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"issue":"3","key":"key20190715155100_B23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis."},{"issue":"21","key":"key20190715155100_B24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med."},{"issue":"10043","key":"key20190715155100_B25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet."}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:51:32Z","timestamp":1563220292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/evaluation-and-reconditioning-of-donor-organs-for-transplantation-through-ex-vivo-lung-perfusion\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7,11]]}},"alternative-id":["10.31744\/einstein_journal\/2019RW4628"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2019rw4628","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"eRW4628"}}